Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac for Capecitabine-Induced Hand-Foot Syndrome
NCT05641246Phase 2Completed
- Sponsor
- German University in Cairo
- Start
- Dec 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diclofenac in hand-foot syndrome (HFS), sponsored by German University in Cairo. Started Dec 2022; status: completed.
02
Drugs
diclofenac
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT05641246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641246.